EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of nurse shark V NAR single‐domain antibodies targeting the spike S2 subunit of SARS‐CoV ‐2

Jesse Buffington, Zhijian Duan, Hyung Joon Kwon, Jessica Hong, Dan Li, Mingqian Feng, Hang Xie, Mitchell Ho iD

The FASEB Journal · 2023

DOI: 10.1096/fj.202202099rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Jesse Buffington und 7 weiteren Autor:innen. Beteiligte Einrichtung: Antibody Engineering Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: COVID-19, Single-Domain Antibodies, Bacteriophages. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS‐CoV‐2 is the etiological agent of the COVID‐19 pandemic. Antibody‐based therapeutics targeting the spike protein, specifically the S1 subunit or the receptor binding domain (RBD) of SARS‐CoV‐2, have gained attention due to their clinical efficacy in treating patients diagnosed with COVID‐19. An alternative to conventional antibody therapeutics is the use of shark new antigen variable receptor domain (V NAR ) antibodies. V NAR s are small (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Single-Domain AntibodiesBacteriophagesHumansSARS-CoV-2PandemicsAntibodiesAntibodies, ViralAntibodies, Neutralizing

Stichwörter der Autor:innen

COVID-19SARS-CoV-2neutralizing antibodyshark VNARsingle-domain antibodyspike S2 subunit

Substanzen

Single-Domain AntibodiesAntibodiesAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Antibody Engineering Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland, USA.
  • Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

ORCID-Profile: Mitchell Ho

Förderung

  • Intramural NIH HHS
  • National Institutes of Health

Zitieren

APA

Buffington, J., Duan, Z., Kwon, H. J., Hong, J., Li, D., Feng, M., Xie, H., & Ho, M. (2023). Identification of nurse shark V NAR single‐domain antibodies targeting the spike S2 subunit of SARS‐CoV ‐2. The FASEB Journal. https://doi.org/10.1096/fj.202202099rr

Vancouver

Buffington J, Duan Z, Kwon HJ, Hong J, Li D, Feng M, et al. Identification of nurse shark V NAR single‐domain antibodies targeting the spike S2 subunit of SARS‐CoV ‐2. The FASEB Journal. 2023. doi:10.1096/fj.202202099rr

BibTeX
@article{Buffington2023,
  author = {Buffington, Jesse and Duan, Zhijian and Kwon, Hyung Joon and Hong, Jessica and Li, Dan and Feng, Mingqian and Xie, Hang and Ho, Mitchell},
  title = {Identification of nurse shark V NAR single‐domain antibodies targeting the spike S2 subunit of SARS‐CoV ‐2},
  journal = {The FASEB Journal},
  year = {2023},
  doi = {10.1096/fj.202202099rr}
}
Kostenlos starten →